科学的演变和对减少危害的认识
Ashley Wurth1, Mollie Bolick2, Tyler Yates3
1Overdose Prevention Team, Injury and Violence Prevention Branch, North Carolina Division of Public Health.
North Carolina medical journal
|November 4, 2024
概括
减少危害的策略正在挽救生命,在恶化的过量危机中. 这篇文章探讨了他们的历史,对北卡罗来纳州的影响以及潜在的挑战.
科学领域:
- 公共卫生 公共卫生
- 成 药物 药物 药物 药物
- 社会学 社会学 社会学
背景情况:
- 过量使用危机对公共卫生构成了重大且日益恶化的挑战.
- 现有的干预措施在缓解过量死亡的有效性方面有所不同.
- 了解减少危害的历史背景和当前应用是至关重要的.
研究的目的:
- 在过量危机中为减少危害提供历史背景.
- 为了检查北卡罗来纳州减少危害策略的拯救生命的影响.
- 识别阻碍减少危害工作有效性的挑战.
主要方法:
- 对减少危害的原则和政策的历史分析.
- 在北卡罗来纳州实施减少危害的案例研究.
- 对减少伤害服务障碍的定性评估.
主要成果:
- 减少危害有着长期缓解毒品相关危害的历史.
- 在北卡罗来纳州,具体的减少伤害策略显然挽救了生命.
- 障碍包括资金,耻辱和政策限制.
结论:
- 减少危害是解决过量危机的重要组成部分.
- 持续支持和扩大减少伤害服务是必不可少的.
- 克服所识别的挑战将增强这些救命干预措施的影响.
相关概念视频
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Drug Abuse and Addiction: Pharmacological Phenomena
445
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
445
Drug Control Governance: Regulatory Bodies and Their Impact
144
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
144
Criticisms of the Evolutionary Perspective
91
In a study where individuals posing as strangers offered compliments and proposed casual sex to students, the responses differed significantly based on gender. Not a single woman accepted the proposal, while 70% of the men agreed. This outcome provides a useful scenario to explore through the lens of evolutionary psychology and social learning theory, highlighting the diverse perspectives on human sexual behaviors.
Evolutionary psychology provides one explanation for these findings, suggesting...
Evolutionary psychology provides one explanation for these findings, suggesting...
91
Hallucinogens and Psychedelics
157
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
157
Pharmacovigilance
776
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
776


